NCT03882892View on ClinicalTrials.gov

Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 2, 2001

Primary Completion Date

August 8, 2002

Study Completion Date

August 8, 2002

Conditions
Hypercholesterolemia
Interventions
DRUG

Ezetimibe

Ezetimibe 10 mg tablets

DRUG

Atovastatin

Atorvastatin 10, 20, and 40 mg tablets at a daily dose of 10 to 80 mg

DRUG

Placebo

Placebo tablets matched to ezetimibe

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT03882892 - Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017) | Biotech Hunter | Biotech Hunter